Genome Review

Regional Breakdown

The European operator profile fits naturally. UK, Ireland, Malta, Cyprus, Estonia, Bulgaria and Curacao-licensed companies with an EU operating presence all integrate cleanly. SEPA Instant settles across Eurozone banks in 10 seconds, the same headline number every SEPA-Instant participant cites. SWIFT handles GBP and USD international corridors but at standard SWIFT pricing, which is not where Genome competes. Non-EEA residents who want a personal account pay €20/month versus zero for EEA holders, a structural pricing signal that the product is built for Europe first.

Verticals

iGaming is the marketed focus: Genome attends SiGMA Europe, iGB Affiliate, ICE Barcelona and i-Con Limassol annually and publishes iGaming-tagged blog content monthly. Forex brokers and affiliate-marketing networks are the next two priority verticals. eCommerce and transportation receive support but aren't the primary positioning. Genome's high-risk pricing track signals openness to verticals mainstream EU banks reject (gambling, adult, forex, affiliate, certain CBD/nutraceutical categories), but each application goes through individual KYB compliance review.

• iGaming
• Forex
• Affiliate marketing
• eCommerce
• Crypto-adjacent businesses
• Transportation

Deposits via Open Banking are instant. The other deposit route is a SEPA transfer, and Genome takes no card deposits. SEPA Instant payouts clear in under 10 seconds inside the Eurozone, day or night. SEPA Credit payouts settle the next business day. SWIFT transfers run a standard 1-3 business days depending on corridor. For SEPA-zone player payouts, Genome's speed profile is strong, comparable to dedicated Open Banking specialists. For FX-corridor settlement, it is standard PSP timing with no particular advantage.

Integration Assessment

A single REST API at developers.genome.eu covering pay-ins, payouts and webhook subscriptions. HmacSHA256 webhook signatures with exponential-backoff retry and an attemptMax counter, so the webhooks are well-engineered. Before going live, test payments run on the XTS test currency, and the callback marks them with an is_test flag. A Hosted Payment Page ("Host-to-Host") runs the checkout on Genome's side and reports each result to the operator by callback. Genome publishes Java and PHP merchant client libraries, last updated in November 2025 and still in alpha, which build hosted-payment-page redirects and check callback signatures. Its public GitHub organization also holds iOS and Android SDKs from October 2021, built for a card checkout Genome does not run. The CMS plugins there for WooCommerce, Magento, PrestaShop, OpenCart, OXID, Drupal and Ecwid were last updated between 2019 and 2021. No pre-built iGaming platform connectors. Documentation quality is Good, with clear endpoint references and webhook examples, but you build everything else against the raw API.

Compliance Context

PCI DSS compliance. PSD2-compliant Open Banking with SCA on the pay-by-bank flow. GDPR-aligned data residency in the EU. ISO 27001 and ISO 27701 certified. DORA operational-resilience compliance as of the EU rollout. Player deposits arrive by Pay by Bank and SEPA transfer, push payments with no chargeback mechanism. Fraud detection is a combination of internal rules, transaction risk scoring and sanctions screening. Genome has not published a third-party fraud vendor (no Sift, Riskified, Forter, Ravelin) and there is no documented machine-learning model for adaptive risk scoring.

Regulatory Position

Electronic Money Institution licensed by the Bank of Lithuania since 2018, authorization LB000453, in force with no end date and no restrictions. The Bank of Lithuania register carries one enforcement measure against the license holder: on June 11, 2024, a warning with an EUR 80,000 fine for breaches of the Lithuanian money laundering prevention law and the regulator's AML and CFT guidelines, covering customer due diligence and reporting obligations. The license itself is live and unrestricted, with no end date. Lithuanian EMI passporting covers all EEA member states. PCI DSS compliant. PSD2 implementing Open Banking. GDPR data-residency aligned. DORA operational-resilience compliant. There is no standalone gambling regulator license, since Genome is a payments licensee rather than a gambling supplier, so MGA, UKGC and Curacao operator licenses sit on the operator side. Player deposits arrive by Pay by Bank and SEPA transfer, push payments with no chargeback mechanism, and Genome runs no card acquiring yet.

Review Analysis

3.5/5 Trustpilot from 309 reviews. The headline average masks a brutally polarized distribution (early-2026 snapshot: 52% 5-star and 41% 1-star) with very little in the middle. Positive reviews praise the clear web UI, the iOS and Android consumer apps, fast SEPA Instant transfers, and customer support that answers within minutes on routine questions. Negative reviews, and there are a lot of them, cluster on three themes: incoming transfers frozen during AML review with vague terms cited, account closures after long verification cycles with documentation requests that users perceive as endless, and money held for over a month with slow responses from compliance. The pattern is consistent with the structural friction of running high-risk merchant compliance from a single Lithuanian EMI shell, though the Bank of Lithuania issued this entity a 2024 warning and EUR 80,000 fine for customer due diligence and reporting breaches, so the friction is not purely structural: when AML triggers fire, the customer experience drops off a cliff.

Context for Operators

Two structural factors matter when reading the Trustpilot score. First, Genome's review base is mostly consumer-side IBAN users rather than B2B merchant operators, so the score reflects the personal-account experience more than the merchant experience. Second, the 41% 1-star tail is unusual but not unprecedented for EMIs serving high-risk verticals. Wise has had similar polarized periods, and Revolut has had worse. The Lithuanian EMI category as a whole carries this reputation risk because the regulator (the Bank of Lithuania) is stricter on AML triggers than the marketing suggests, and customers experience that friction as the EMI's fault rather than the regulator's. Operators evaluating Genome for merchant acquiring should weight Trustpilot less than peer references inside the iGaming compliance community.

Client Evidence

Genome does not publicly disclose specific iGaming operator clients. The Trustpilot review base (309 reviews) skews toward consumer personal-account users rather than B2B merchant operators, which leaves the B2B reputation hard to read. Conference photography from SiGMA and iGB suggests an active mid-market iGaming merchant pipeline. The structural client profile is European operators that don't qualify for tier-1 enterprise PSPs and want a Bank of Lithuania-regulated shell as the operational layer.